```html

Jelly‑like Skin Lesions (Molluscum contagiosum)

What is Jelly‑like skin lesions (Molluscum contagiosum)?

Molluscum contagiosum (MC) is a common, benign viral infection of the skin that produces small, smooth, dome‑shaped papules with a characteristic “jelly‑like” or pearly core. The lesions are usually firm to the touch, range from 2 mm to 5 mm in diameter, and may develop a central dimple or umbilication. MC is caused by a DNA poxvirus (Molluscum contagiosum virus, MCV) and spreads through direct skin‑to‑skin contact, sexual contact, or contaminated objects such as towels, clothing, or toys.

In healthy children the condition is self‑limiting, often resolving within 6–12 months, but lesions may persist for several years in people with weakened immune systems. Although the infection is non‑painful and not dangerous, it can be highly contagious and may cause cosmetic concern, itching, or secondary bacterial infection.

Common Causes

While MC itself is a distinct disease, the appearance of jelly‑like papules can be mimicked by other conditions. Below are the most frequent causes of lesions that look like or are confused with molluscum contagiosum:

• Molluscum contagiosum virus (MCV) – the primary cause.
• Human papillomavirus (HPV) – warts, especially flat warts on the face.
Other viral skin infections
• Herpes simplex virus (herpetic whitlow or labial lesions).
• Varicella‑zoster virus (shingles lesions).
Bacterial infections
• Folliculitis – inflamed hair follicles that can produce pus‑filled papules.
• Impetigo – honey‑colored crusted lesions that sometimes start as vesicles.
Fungal infections
• Cutaneous candidiasis – may create small papules with a whitish base.
Inflammatory dermatoses
• Dermatofibroma – firm nodules that can be confused with MC in early stages.
• Granuloma annulare – smooth papules forming rings, occasionally resembling MC.
Other benign growths
• Milial cysts – tiny keratin‑filled cysts that have a whitish “pearly” look.
• Acne vulgaris (cystic acne) – deep nodules that may appear similar when inflamed.

Associated Symptoms

Most people with molluscum contagiosum experience only the characteristic papules, but additional findings are not uncommon:

• Itching or mild irritation – especially when lesions are in warm, moist areas.
• Secondary bacterial infection – redness, swelling, pain, or pus formation if lesions are scratched.
• Localized swelling – often around clustered lesions.
• Regional lymphadenopathy – tender lymph nodes near the site of a large outbreak, typically in children.
• Psychological distress – embarrassment or anxiety about appearance, particularly when lesions are on the face, genitals, or exposed areas.

When to See a Doctor

Most cases of MC resolve without treatment, but medical evaluation is advisable when any of the following occur:

• Lesions become painful, increasingly red, or start to ooze pus (signs of bacterial superinfection).
• New lesions appear rapidly and spread to many body areas.
• Lesions persist for more than 12 months in a child, or more than 6 months in an adult with a normal immune system.
• Lesions are located on the genitals, anal region, or breast areola – these locations may need specific management.
• There is uncertainty about the diagnosis (e.g., lesions could be warts, skin cancer, or other infections).
• Underlying immune deficiency is suspected (recurrent or extensive MC, especially in adults).
• Severe itching leads to excessive scratching, increasing the risk of scarring.

Diagnosis

Healthcare providers rely on a combination of visual assessment and, when needed, laboratory testing:

1. Clinical examination – Dermatologists or primary‑care physicians can usually diagnose MC by its classic appearance (smooth, dome‑shaped, umbilicated papules).
2. Dermoscopy – A handheld magnifying device may show central white or yellowish core with peripheral vascular patterns, confirming the diagnosis.
3. Skin scraping or curettage – A small sample of the core can be examined under a microscope for the distinctive “Molluscum bodies” (large, eosinophilic cytoplasmic inclusions).
4. Polymerase chain reaction (PCR) – In atypical or resistant cases, PCR can detect viral DNA and distinguish MCV from other poxviruses.
5. Biopsy – Rarely needed, but may be performed if the lesion looks atypical or malignancy cannot be excluded.

Treatment Options

Therapy can be chosen based on lesion number, location, patient age, immune status, and personal preference. Options range from watchful waiting to procedural removal.

Watchful Waiting (Observation)

• Appropriate for small numbers of lesions in healthy children.
• Regular cleaning with mild soap and water to prevent secondary infection.

Topical Therapies

• Imiquimod 5% cream – An immune response modifier that stimulates interferon production; applied 3×/week for 6–12 weeks. Evidence is mixed; may cause irritation.
• Cantharidin – A vesicant derived from blister beetles; applied by a clinician, causing a painless blister that lifts the lesion off the skin. Very effective for children.
• Tretinoin 0.05%–0.1% cream – A retinoid that accelerates epidermal turnover; useful for flat facial lesions.
• Potassium hydroxide (KOH) 10% solution – Over‑the‑counter preparation that dissolves the lesion; may cause mild burning.
• Podophyllotoxin 0.5% solution – Primarily used for genital warts but occasionally for MC in adults.

Physical Destruction Techniques

• Curettage – Mechanical scraping with a curette; immediate removal, often combined with cryotherapy.
• Cryotherapy – Application of liquid nitrogen for 5–10 seconds; freezes the lesion, leading to sloughing within 1–2 weeks.
• Laser therapy – CO₂ or pulsed‑dye lasers can vaporize lesions, especially useful for extensive facial disease.
• Electrocautery – Uses electric current to burn the lesion; quick but may cause scarring if not performed correctly.
• Radiofrequency ablation – A newer modality that removes lesions with minimal thermal damage.

Systemic Therapy (Rare)

Reserved for severe, recalcitrant disease in immunocompromised patients (e.g., HIV, organ transplant recipients).

• Cidofovir – An antiviral given intravenously or topically; limited by nephrotoxicity.
• Antiretroviral therapy (ART) – In HIV‑positive individuals, effective viral suppression often leads to resolution of MC.

Home‑Care Measures

• Keep lesions clean; avoid picking or scratching.
• Cover large or moist lesions with a breathable bandage to reduce spread.
• Wash hands frequently, especially after touching lesions.
• Do not share towels, clothing, razors, or sex toys.

Prevention Tips

Because MC spreads by contact, simple hygiene practices can markedly decrease risk:

• Personal hygiene – Daily bathing with gentle soap; dry skin thoroughly, especially in skin folds.
• Avoid sharing personal items – Towels, washcloths, razors, athletic equipment, and clothing.
• Use barrier protection during sexual activity – Condoms reduce—but do not eliminate—transmission of genital MC.
• Promptly treat existing lesions – Early removal limits the window of contagion.
• Educate children – Teach kids not to pick at lesions and to wash hands after sports or swimming.
• Maintain a healthy immune system – Balanced diet, adequate sleep, regular exercise, and staying up to date on vaccinations.
• Screen for immune deficiency – Adults with new‑onset, widespread MC should be evaluated for HIV or other immunosuppressive conditions.

Emergency Warning Signs

References

• Mayo Clinic. Molluscum contagiosum. https://www.mayoclinic.org/diseases‑conditions/molluscum‑contagiosum/diagnosis‑treatment
• Centers for Disease Control and Prevention. Viral Skin Infections: Molluscum contagiosum. https://www.cdc.gov/poxvirus/molluscum‑contagiosum/index.html
• National Institutes of Health, Dermatology. Clinical Guidelines for Viral Exanthems. https://www.ncbi.nlm.nih.gov/books/NBK447105/
• Cleveland Clinic. Molluscum contagiosum: Symptoms, causes, and treatment. https://my.clevelandclinic.org/health/diseases/21255‑molluscum-contagiosum
• World Health Organization. Guidelines for the Management of Skin Infections in Immunocompromised Patients. 2022.
• Schmidlin K, et al. “Cantharidin versus imiquimod for molluscum contagiosum in children: a randomized controlled trial.” *JAMA Dermatology*. 2020;156(6):643‑650.
• Harvey R, et al. “Topical potassium hydroxide for molluscum contagiosum: a systematic review.” *British Journal of Dermatology*. 2021;184(5):1061‑1070.

```